Cartalax

Description

Cartalax — Synthetic Tripeptide Bioregulator (Ala-Glu-Asp)

Cartalax is a synthetic tripeptide (Ala-Glu-Asp) studied for its role in chondrocyte protein synthesis regulation. It is supplied for in vitro laboratory research only.

Research context

Preclinical literature has examined Cartalax’s effect on protein synthesis normalization within chondrocyte cell cultures. Investigators have studied its influence on collagen and proteoglycan synthesis pathways in cartilage-derived cell models. Model systems include isolated chondrocyte cultures used to examine gene-expression and extracellular-matrix signaling.

Specification

• Available sizes: 20mg
• Form: lyophilised powder
• Purity: ≥99% (HPLC)
• Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot

For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.

Related Research

Compound family: Epithalon, Cortagen, Crystagen, B7-33

Browse: Cellular & Tissue Research · All Research Peptides

Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.